Russia’s Medtech Revolution
Executive Summary
Russia’s health care authorities are building a modern system to meet the needs of a growing population and better regulation of entry into the $6 billion medical device market is an important element of this wider aim. Alexandra Tretiakova, executive director of Russia’s International Medical Device Manufacturers Association, weighs in on how the complex new set of rules will impact the medtech industry.
You may also be interested in...
Flurry of Russian Medtech Regulatory System Proposals Keeps Manufacturers On Their Toes
Russian medtech industry expert Alexey Stepanov reports an uptick in regulatory activity nationally in the final trimester of 2016. The catalyst seems to be the impending launch of the system of harmonization of medical device regulation within the regional Eurasian Economic Union (EAEU).
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.